RSS

cellular therapy

A Master Service Agreement has been entered by TxCell and Lonza Pharma & Biotech for the manufacture of a CAR-Treg cellular product (TX200), which is in development for the prevention of chronic rejection after organ transplantation. more

News

The ISCT International Society Cell and Gene Therapy has announced its support of the US Food and Drug Administration’s request for injunctions against two US stem cell clinics that have administered unproven cellular therapy treatments to patients. more

News

CiMaas, a developer of cellular immunotherapy for cancer, and PharmaCell, a contract manufacturer for cellular therapies and regenerative medicine in Europe, are collaborating in the clinical development of CiMaas’ products. more

News

CTL019, is the first personalised cellular therapy for the treatment of cancer to receive this important classification. more